News

Firm Announcements and Updates

HGT Law Files Consolidated Class Action Complaint Against Organizers of the Tezos ICO for Violations of Securities Laws

On April 3, 2018, HGT Law (who previously had been appointed lead counsel by the court) filed a consolidated class action complaint against Defendants Dynamic Ledgers Solutions, Inc. (“DLS”), Tezos Stiftung (“Tezos Foundation”), Kathleen Breitman, Arthur Breitman, Timothy Draper, Draper Associates V Crypto LLC and Bitcoin Suisse AG for violations of the Securities Act of 1933. 

Read More
gene lu
HGT Law Commences a Second Securities Fraud Action Against Valeant Pharmaceuticals and its Senior Officers on Behalf of Retail Investors

On January 19, 2018, HGT Law commenced a second shareholder “opt-out” lawsuit (“Lawsuit”) on behalf of a group of retail investors (“Investors”) against Valeant Pharmaceuticals International, Inc. (“Valeant”) and its senior officers for violations of federal securities laws.  To date, this Lawsuit is the only opt-out action that has been filed on behalf of retail investors.

Read More
gene lu
HGT Law Commences Securities Fraud Action Against Valeant Pharmaceuticals and its Senior Officers

On January 10, 2018, HGT Law commenced a shareholder “opt-out” lawsuit (“Lawsuit”) on behalf of the investment funds Commonwealth Global Shares Fund 1, Commonwealth Global Share Fund 13 and Commonwealth Specialist Fund 34 (collectively, “Plaintiffs” or the “Funds”) against Valeant Pharmaceuticals International, Inc. (“Valeant” or the “Company”) and its senior officers for violations of federal securities laws.

Read More
gene lu
HGT Law Commences Derivative Lawsuit Against Directors And Officers Of McKesson Corporation For Its Role In National Opioid Epidemic

On October 17, 2017, HGT Law filed a shareholder derivative lawsuit (“Lawsuit”) on behalf of the shareholders of McKesson Corporation (“McKesson” or the “Company”) against various McKesson directors and officers for abdicating their fiduciary duty of oversight with respect to the Company’s sale of opioid drugs and controlled substances.

Read More
gene lu